Wells Fargo Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Connor Siversky has maintained an Equal-Weight rating on Sabra Health Care REIT (NASDAQ:SBRA) and raised the price target from $13 to $15.
October 17, 2023 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Sabra Health Care REIT and raised the price target from $13 to $15.
The raised price target indicates that the analyst sees potential for the stock's price to increase. This could lead to positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100